The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer

Correlation of GPNMB expression with outcome in breast cancer (BC) patients treated with the antibody–drug conjugate (ADC), CDX-011 (CR011-vcMMAE).

(2017) M. N. Saleh et al.   JOURNAL OF CLINICAL ONCOLOGY

New Antibody Conjugates in Cancer Therapy

(2011) Serengulam V. Govindan et al.   TheScientificWorldJOURNAL

Immunological Approaches in the Treatment of Metastasized Breast Cancer

(2010) Volkmar Müller et al.   Breast Care

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Glycoprotein Nonmetastatic B Is an Independent Prognostic Indicator of Recurrence and a Novel Therapeutic Target in Breast Cancer

(2010) A. A. N. Rose et al.   CLINICAL CANCER RESEARCH

Antibody–drug conjugates: targeted drug delivery for cancer

(2010) Stephen C Alley et al.   CURRENT OPINION IN CHEMICAL BIOLOGY